...
首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Safety and efficacy of multiple cyclocoagulation of ciliary bodies by high-intensity focused ultrasound in patients with glaucoma
【24h】

Safety and efficacy of multiple cyclocoagulation of ciliary bodies by high-intensity focused ultrasound in patients with glaucoma

机译:高强度聚焦超声在青光眼患者中对睫状体多环凝血的安全性和疗效

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Purpose To evaluate long-term efficacy and safety of repeated ultrasonic circular cyclocoagulation (UCCC) in patients with uncontrolled glaucoma. Methods Forty eyes of 40 patients affected by primary or secondary uncontrolled glaucoma under maximal tolerated medical therapy were enrolled in this prospective non-comparative case series study. A complete ophthalmic examination was performed before and after each month for 1?year. The UCCC treatment was repeated at 4?months if the intraocular pressure (IOP) was >?21?mmHg without major complications. Complete success was defined as a final IOP?>?5?mmHg and ≤?21?mmHg without hypotensive medication adjunction and no major or vision-threatening complications. Results The mean preoperative IOP was 32.5?±?9.9?mmHg. Four months after the first UCCC treatment the overall IOP reduction was 27.8%. Twenty-two of the treated eyes did not achieve the complete success and a second treatment was performed in 20 of these eyes. Four months after the second UCCC procedure, the IOP reduction was 20.3% from preoperative values and 34.7% from baseline. Twelve of the retreated eyes needed a third treatment. Four months after the third UCCC treatment, the overall IOP reduction was 34% and 52.6% from baseline. No major complications occurred during or after any of the procedures. At 12?months, complete success was achieved in 85% (34/40) of treated eyes, with a maximum of three procedures and a significant medication reduction. Conclusions Multiple UCCC treatments are safe, and additional treatments increase the overall procedure efficacy.
机译:摘要目的,用于评估患有不受控制的青光眼患者重复超声圆环凝血(UCCC)的长期疗效和安全性。方法在最大耐受药物治疗下受到初级或次级不受控制的青光眼影响的40名患者的40名患者均注册了该潜在的非比较案例系列研究。在每个月之前和之后进行完整的眼科检查,持续1岁。如果舌内压(IOP)> 21mmHg,则在4个月内重复uccc治疗,没有主要并发症。完成成功被定义为最终IOP?>?5?mmhg和≤212mmhg,没有低度药物的药物,没有主要或视力威胁的并发症。结果平均术前IOP为32.5?±9.9?mmhg。第一次UCCC治疗后四个月,整体IOP还原为27.8%。二十二人治疗的眼睛没有达到完全成功,第二种治疗在其中20只眼睛中进行。在第二个UCCC程序后四个月,从术前值的IOP还原为20.3%,从基线到34.7%。 12岁的后退眼睛需要第三种治疗方法。第三个UCCC治疗后四个月,总体IOP还原为基线的34%和52.6%。任何程序期间都没有发生重症并发症。在12?几个月时,在85%(34/40)的治疗眼中取得了完全成功,最多三种程序和显着的药物减少。结论多种UCCC治疗是安全的,另外的治疗增加了整体过程的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号